Medscape55m
FDA OKs Esketamine Nasal Spray Monotherapy for Resistant Depression
The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...
Healio2d
FDA approves Spravato as monotherapy for adults with major depressive disorder
The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as ...
The American Journal of Managed Care3d
Esketamine Approved by FDA as First Monotherapy for Treatment-Resistent Depression
Esketamine (Spravato; Johnson & Johnson) is now the first and only monotherapy for adults with major depressive disorder (MDD ...
Managed Healthcare Executive2d
FDA Approves Spravato Nasal Spray as a Standalone Treatment for Major Depressive Disorder
One-third of folks with major depressive disorder experience treatment-resistant depression (TRD), a condition that makes it ...
health.wusf.usf.edu2d
FDA allows standalone use of nasal spray antidepressant Spravato (esketamine)
The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...
Interesting Engineering on MSN1d
US approves first nasal spray for major depressive disorder, PTSD conditions
Johnson & Johnson has announced a major breakthrough in mental health treatment. The Food and Drug Administration (FDA) has approved Spravato, a novel nasal spray, for the standalone treatment of ...
Hosted on MSN2d
FDA Expands Approval of Esketamine for Depression
The FDA approved esketamine (Spravato) nasal spray as monotherapy for adults with treatment-resistant depression who had an ...
Putnam Daily Voice3d
Nasal Spray Treating Major Depression Receives FDA Approval For Standalone Use
The FDA granted approval to Spravato (esketamine) as the first monotherapy for adults ... about one-third of the estimated 21 million U.S. adults living with major depressive disorder.
Psychology Today16d
Ketamine-Assisted Psychiatrists in Asheville, NC
and Major Depressive Disorder (MDD) with acute suicidal ideation or behavior. We offer Spravato intranasal esketamine and intramuscular ketamine treatment therapy to patients in western North ...
CounterPunch21d
Psychiatry’s Latest Insane Magic-Bullet Treatment for Depression: Why Ketamine?
“A single dose of intravenous ketamine compared to placebo has no short-term effect on the severity of depression symptoms in adults with major depressive disorder . . . . Our results suggest ...